Gulf Island Fabrication, Inc. (NASDAQ: GIFI), announced today that,
through its subsidiary Gulf Island L.L.C., it has signed a contract for
the fabrication of five (5) Jacket/Piles for the Block Island Wind Farm,
a shallow water Wind Turbine project located in the Atlantic Ocean off
the coast of Rhode Island being developed by Deepwater Wind.
KB004 Phase 1/2 Clinical Data in Hematologic Malignancies to be presented at the 56th American Society of Hematology Annual Meeting and Exposition Management to present at the Stifel 2014 Healthcare Conference
SOUTH SAN FRANCISCO, Calif.
Fiscal Second Quarter Shows Significant Revenues and Growth Investment; Q2 Revenues up 68% to Record $15.7 Million with Net Income of $0.04 per Share; Company Raises Fiscal 2015 Guided Revenues to $57.0-$59.0 Million and Net Income to $8.0-$9.5 Million
LINDON, Utah, Nov.
Waters Corporation (NYSE:WAT) Gene Cassis, Chief Financial Officer, will
speak to the investment community at the Stifel 2014 Healthcare
Conference at the New York Palace Hotel in New York, on Tuesday,
November 18, 2014, at 8:00 a.m. Eastern Time.
Sign-up for 2014/11/11 - Lifshitz & Miller Law Firm Announces Investigation of Barrett Business Services, Inc., Bio-Rad Laboratories, Inc., Pingtan Marine Enterprise Ltd., Rayonier Inc. and Salix Pharmaceuticals, Ltd. investment picks
By Sue Chang, MarketWatch , Mark DeCambreFossil set to report earnings after the close Tuesday
SAN FRANCISCO (MarketWatch) -- These are the stocks making notable moves in the market on Tuesday:
Juniper Networks Inc. (JNPR) late Monday named Rami Rahim chief executive officer, replacing Shaygan Kheradpir, who resigned with immediate effect.
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and
development-focused biotechnology company dedicated to creating small
molecule drugs in the infectious disease field, today announced at The
Liver Meeting ® 2014 results from studies in chronic hepatitis
C virus (HCV) patients with human immunodeficiency virus type 1 (HIV-1)
co-infection (TURQUOISE-I) and liver transplant recipients (CORAL-I).
New, detailed results from part one of the Phase 2 portion of AbbVie’s
Phase 2/3 open-label study, TURQUOISE-I, showed that patients
co-infected with genotype 1 (GT1) HCV and HIV-1 receiving AbbVie’s
investigational treatment and ribavirin (RBV) for 12 weeks or 24 weeks
achieved a sustained virologic response rate 12 weeks post-treatment (SVR 12 )
of 93.5 percent (n=29/31) and 90.6 percent (n=29/32), respectively.
Sign-up for - Enanta Announces Results from TURQUOISE-I Study in Chronic Hepatitis C Patients with HIV-1 Co-infection and from the CORAL-I Study In Liver Transplant Recipients at The Liver Meeting 2014® investment picks
By Jennifer Booton, MarketWatch How Alibaba answer to Valentine's Day grew bigger than Black Friday
NEW YORK (MarketWatch) -- China's anti--Valentine's Day has handily surpassed the U.S.' s Black Friday as the world's most lucrative online shopping day, and it is well on its way to becoming the most profitable manufactured holiday in history.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.